目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
What's New in This Update?
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Infectious Disease Treatments, by Segment, Through 2026
Figure Summary : Global Market for Infectious Disease Treatments, by Segment, 2020-2026
Chapter- 3: Overview
Top Global Causes of Death
Infectious Diseases
Bacterial Infectious Diseases
Viral Infectious Diseases
Protozoan Infectious Diseases
Factors Responsible for Emergence and Spread
Vaccines
Antibiotics
Chapter- 4: Disease Overview
Hepatitis B and Hepatitis C
Herpes Simplex Virus
HIV/AIDS
Influenza A and Influenza B
Rotavirus
Respiratory Syncytial Virus
Malaria
Tuberculosis
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Viral Hemorrhagic Fevers-Lassa Fever
Viral Hemorrhagic Fevers-Ebola Fever
Viral Hemorrhagic Fevers-Marburg
Viral Hemorrhagic Fevers-Zika Virus
Viral Hemorrhagic Fevers-Yellow Fever
Viral Hemorrhagic Fevers-Dengue
Chapter- 5: Market Dynamics
Infectious Diseases
Hepatitis B
Hepatitis C
Herpes
HIV/AIDS
Influenza A and B
Rotavirus
Respiratory Syncytial Virus
Malaria
Tuberculosis
MERS-CoV
Viral Hemorrhagic Fevers-Lassa
Viral Hemorrhagic Fevers-Ebola
Viral Hemorrhagic Fevers-Marburg
Viral Hemorrhagic Fevers-Zika
Viral Hemorrhagic Fevers-Yellow Fever
Viral Hemorrhagic Fevers-Dengue
Chapter- 6: Impact of COVID-19
History of Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Impact of COVID-19 on Infectious Disease Market
Chapter- 7: Markets and Forecast
Global Market for Infectious Disease Treatments
Global Infectious Diseases
Chapter- 8: Antibiotic Resistance
Overview
Mechanisms of Antibiotic Resistance
Reasons for Antibiotic Resistance
Chapter- 9: Research and Development
Overview
Hepatitis B and Hepatitis C
Herpes Simplex Virus
HIV/AIDS
Influenza A and Influenza B
Rotavirus
Respiratory Syncytial Virus
Malaria
Tuberculosis
MERS
Hemorrhagic Fevers
Chapter- 10: Next-Generation Predictive Tools
Overview
Why Do We Need Forecast Tools?
Tools in Infectious Disease Modeling
Mobile Apps in Infectious Disease Modeling
Current Limitations in Infectious Disease Modeling
Chapter- 11: Patent Analysis
Hepatitis B
Hepatitis C
Herpes Simplex Virus
HIV/AIDS
Influenza
Rotavirus
Respiratory Syncytial Virus
Malaria
Tuberculosis
MERS-CoV
Viral Hemorrhagic Fevers-Lassa
Viral Hemorrhagic Fevers-Ebola
Viral Hemorrhagic Fevers-Marburg
Viral Hemorrhagic Fevers-Zika
Viral Hemorrhagic Fevers-Dengue
Viral Hemorrhagic Fevers-Yellow Fever
Chapter- 12: Competitive Landscape
Mergers and Acquisitions and Collaborations
Market Share of Infectious Disease Market
Chapter- 13: Company Profiles
ABBOTT
ABBVIE INC.
ASTRAZENECA PHARMACEUTICALS
BRISTOL-MYERS SQUIBB CO.
DIASORIN S.P.A.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE
JOHNSON & JOHNSON
MERCK & CO, INC.
NOVARTIS AG
ORASURE TECHNOLOGIES INC.
ROCHE
SANOFI S.A.
SEQIRUS, A CSL CO.
SIEMENS HEALTHINEERS
Chapter- 14: Appendix: Abbreviations
Table 112 : Abbreviations Used in this Report
